Trachoma Prevalence in Women Living in Rural Northern India: Rapid Assessment Findings

Khanduja, Sumeet; Jhanji, Vishal; Sharma, Namrata; Vashist, Praveen; Gupta, Sanjeev Kumar; Satpathy, Gita; Tandon, Radhika; Titiyal, Jeewan S; Vajpayee, Rasik B

doi:10.3109/09286586.2012.657765

Cited by 8 publications

(6 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Around three-quarters of the studied group were females representing 77.2% while males 22.8%, this goes in harmony with Khanduja (2012)[9] as his sample included one thousand females in underdeveloped parts of an Indian villages. Both studies showed approximately a prevalence of trachoma of 31% (in this study 31.1% while in Khanduja was 31.8%).…”

Section: Discussionsupporting

confidence: 73%

The prevalence of chlamydia trachomatis among patients with acute conjunctivitis in kasr alainy ophthalmology clinic

et al. 2014

View full text Add to dashboard Cite

IntroductionTrachoma is a leading cause of avoidable blindness and endemic conjunctivitis in 57 countries. It infects approximately 84 million people globally, and continues to threaten over 10% of the world's population with the risk of blindness.MethodsThis is a cross sectional descriptive study assessing patients presenting with acute conjunctivitis. A full history was taken from patients followed by examination of both eyes. A conjunctival swab was taken and a sample of tears was collected and handled at the central laboratory unit at Kasr AlAiny hospital for culture and sensitivity of the swab and ELISA for tears searching for Immunoglobulin G and Immunoglobulin M of chlamydia trachomatis.ResultsThe prevalence of bacterial conjunctivitis encounted for 45.7% and non-bacterial 54.3% of the studied group. The anti-chlamydial antibodies were positive in the tears of 31.1% of patients. While the other bacterial organisms responsible for 14.6%.ConclusionThe study concluded that trachoma accounts for one third of the cases of acute conjunctivitis while the other bacterial organisms responsible for about 14.6%. More than half of the cases have other causes as viral, allergic, mechanical or chemical induced conjunctivitis.

show abstract

Section: Discussionsupporting

confidence: 73%

The prevalence of chlamydia trachomatis among patients with acute conjunctivitis in kasr alainy ophthalmology clinic

et al. 2014

View full text Add to dashboard Cite

show abstract

“…This is the case in many programs, but the gender gap remains a problem in Oman, which may not successfully eliminate trachoma until coverage is more equal between men and women [40]. In underdeveloped communities of India, as many as one-third of women had trachoma symptoms, but only 40% received any treatment [112]. …”

Section: The Overall Effectiveness Of Safementioning

confidence: 99%

Will the SAFE Strategy Be Sufficient to Eliminate Trachoma by 2020? Puzzlements and Possible Solutions

Lavett

Lansingh

Carter

et al. 2013

The Scientific World Journal

View full text Add to dashboard Cite

Since the inception of (the Global Elimination of Blinding Trachoma) GET 2020 in 1997 and the implementation of the SAFE strategy a year later, much progress has been made toward lowering the prevalence of trachoma worldwide with elimination of the disease in some countries. However, high recurrence of trichiasis after surgery, difficulty in controlling the reemergence of infection after mass distribution of azithromycin in some communities, the incomplete understanding of environment in relation to the disease, and the difficulty in establishing the prevalence of the disease in low endemic areas are some of the issues still facing completion of the GET 2020 goals. In this narrative review, literature was searched from 1998 to January 2013 in PubMed for original studies and reviews. Reasons for these ongoing problems are discussed, and several suggestions are made as avenues for exploration in relation to improving the SAFE strategy with emphasis on improving surgical quality and management of the mass treatment with antibiotics. In addition, more research needs to be done to better understand the approach to improve sanitation, hygiene, and environment. The main conclusion of this review is that scale-up is needed for all SAFE components, and more research should be generated from communities outside of Africa and Asia.

show abstract

“…The success of various health programmes cannot be denied, but the trachoma persisted and now has shown upsurge, due to lack of awareness and interest by government agencies. Trachoma prevalence in India has been reported to be varying between 0.5 to 80 per cent, according to studies conducted across various centers [6][7][8][9][10][11][12][13]. Community studies were conducted to find out the true prevalence of Chlamydia trachomatis infection using laboratory support in the known hyperendemic belt of northern India by the Trachoma Study Group in 1998 (Uttar Pradesh) and later in 2007-2008 (Haryana) [5,9].. Sharma et al from RP Center, AIIMS did a twelve year study (1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008) in rural northern India and has shown the prevalence of trachoma to be persisting in northern India, albeit at a lower level [14].…”

Section: Discussionmentioning

confidence: 99%

Epidemiology of Trachoma: A Report by Sitapur Trachoma Study Group

Mishra¹

2014

J Clin Exp Ophthalmol

View full text Add to dashboard Cite

Trachoma is the most common cause of infectious blindness worldwide and it affects more than 150 million people. Despite of various control programs, it still persists and lead to significant ocular morbidity. We have done Prospective clinical epidemiological study conducted at Regional Institute of Ophthalmology (RIO) & Sitapur Eye Hospital (SHE), Sitapur, Uttar Pradesh, India. RIO & SEH is a large tertiary care hospital working with community since 1935 and serves more than 32 cities and towns in the states of Uttranchal and Uttar Pradesh of India and rest of its 32 branches all over. Cases were selected from our OPD clinic and findings were verified by 2 independent ophthalmologists. Percentage of patients with fresh cases / active trachoma-64 and percentage of patients with active on chronic / old trachoma-36.7%. Trachoma remains still an unconquered scourge.

show abstract

Trachoma Prevalence in Women Living in Rural Northern India: Rapid Assessment Findings

Abstract: The results of our rapid assessment suggest that the presence of cicatricial trachoma remains an important health issue in females over 15 years of age.

Cited by 8 publications

References 11 publications

The prevalence of chlamydia trachomatis among patients with acute conjunctivitis in kasr alainy ophthalmology clinic

The prevalence of chlamydia trachomatis among patients with acute conjunctivitis in kasr alainy ophthalmology clinic

Will the SAFE Strategy Be Sufficient to Eliminate Trachoma by 2020? Puzzlements and Possible Solutions

Epidemiology of Trachoma: A Report by Sitapur Trachoma Study Group

Contact Info

Product

Resources

About